1
|
Lin YS, Tsay RY. Drug Release from a Spherical Matrix: Theoretical Analysis for a Finite Dissolution Rate Affected by Geometric Shape of Dispersed Drugs. Pharmaceutics 2020; 12:pharmaceutics12060582. [PMID: 32585967 PMCID: PMC7357057 DOI: 10.3390/pharmaceutics12060582] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/02/2020] [Revised: 06/20/2020] [Accepted: 06/22/2020] [Indexed: 12/02/2022] Open
Abstract
Amending the neglect of finite dissolution in traditional release models, this study proposed a more generalized drug release model considering the simultaneous dissolution and diffusion procedure from a drug-loaded spherical matrix. How the shape factor (n = 0, 1/2, and 2/3 for the planar, cylindrical, and spherical geometry, respectively) of dispersed drug particles affected the release from the matrix was examined for the first time. Numerical solutions of this generalized model were validated by consensus with a short-time analytical solution for planar drugs and by the approach of the diffusion-controlled limits with Higuchi’s model. The drug release rate increases with the ratio of dissolution/diffusion rate (G) and the ratio of solubility/drug loading (K) but decreases with the shape factor of drug particles. A zero-order release profile is identified for planar drugs before starting the surface depletion layer, and also found for cylindrical and spherical dispersed drugs when K and G are small, i.e. the loaded drug is mainly un-dissolved and the drug release rate is dissolution-controlled. It is also shown that for the case of a small G value, the variation of drug release profile, due to the drug particle geometry, becomes prominent. Detailed comparison with the results of the traditional Higuchi’s model indicates that Higuchi’s model can be applied only when G is large because of the assumption of an instantaneous dissolution. For K = 1/101–1/2, the present analysis suggests an error of 33–85% for drug release predicted by Higuchi’s model for G = 100, 14–44% error for G = 101, while a less than 5% error for G ≧ 103.
Collapse
Affiliation(s)
- Yung-Sheng Lin
- Department of Chemical Engineering, National United University, Miaoli 36063, Taiwan
- Correspondence: (Y.-S.L.); (R.-Y.T.); Tel.: +886-37-38-2199 (Y.-S.L.); +886-2-2826-7024 (R.-Y.T.)
| | - Ruey-Yug Tsay
- Department of Biomedical Engineering, National Yang-Ming University, Taipei 11221, Taiwan
- Center for Advanced Pharmaceutics and Drug Delivery Research, National Yang-Ming University, Taipei 11221, Taiwan
- Correspondence: (Y.-S.L.); (R.-Y.T.); Tel.: +886-37-38-2199 (Y.-S.L.); +886-2-2826-7024 (R.-Y.T.)
| |
Collapse
|
2
|
Nuxoll E. Added release time in diffusion/dissolution coupled release. Int J Pharm 2015; 494:195-204. [PMID: 26276252 DOI: 10.1016/j.ijpharm.2015.08.017] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/24/2015] [Revised: 08/01/2015] [Accepted: 08/05/2015] [Indexed: 11/25/2022]
|
3
|
Snorradóttir BS, Jónsdóttir F, Sigurdsson ST, Másson M. Numerical modelling of transdermal delivery from matrix systems: parametric study and experimental validation with silicone matrices. J Pharm Sci 2014; 103:2366-75. [PMID: 24984880 DOI: 10.1002/jps.24052] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/26/2014] [Revised: 05/12/2014] [Accepted: 05/16/2014] [Indexed: 11/12/2022]
Abstract
A model is presented for transdermal drug delivery from single-layered silicone matrix systems. The work is based on our previous results that, in particular, extend the well-known Higuchi model. Recently, we have introduced a numerical transient model describing matrix systems where the drug dissolution can be non-instantaneous. Furthermore, our model can describe complex interactions within a multi-layered matrix and the matrix to skin boundary. The power of the modelling approach presented here is further illustrated by allowing the possibility of a donor solution. The model is validated by a comparison with experimental data, as well as validating the parameter values against each other, using various configurations with donor solution, silicone matrix and skin. Our results show that the model is a good approximation to real multi-layered delivery systems. The model offers the ability of comparing drug release for ibuprofen and diclofenac, which cannot be analysed by the Higuchi model because the dissolution in the latter case turns out to be limited. The experiments and numerical model outlined in this study could also be adjusted to more general formulations, which enhances the utility of the numerical model as a design tool for the development of drug-loaded matrices for trans-membrane and transdermal delivery.
Collapse
|
4
|
Application of numerical methods for diffusion-based modeling of skin permeation. Adv Drug Deliv Rev 2013; 65:208-20. [PMID: 22261307 DOI: 10.1016/j.addr.2012.01.001] [Citation(s) in RCA: 32] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/04/2011] [Revised: 12/23/2011] [Accepted: 01/03/2012] [Indexed: 11/22/2022]
Abstract
The application of numerical methods for mechanistic, diffusion-based modeling of skin permeation is reviewed. Methods considered here are finite difference, method of lines, finite element, finite volume, random walk, cellular automata, and smoothed particle hydrodynamics. First the methods are briefly explained with rudimentary mathematical underpinnings. Current state of the art numerical models are described, and then a chronological overview of published models is provided. Key findings and insights of reviewed models are highlighted. Model results support a primarily transcellular pathway with anisotropic lipid transport. Future endeavors would benefit from a fundamental analysis of drug/vehicle/skin interactions.
Collapse
|
5
|
Naegel A, Heisig M, Wittum G. Detailed modeling of skin penetration--an overview. Adv Drug Deliv Rev 2013; 65:191-207. [PMID: 23142646 DOI: 10.1016/j.addr.2012.10.009] [Citation(s) in RCA: 59] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/21/2011] [Revised: 06/28/2012] [Accepted: 10/17/2012] [Indexed: 11/20/2022]
Abstract
In recent years, the combination of computational modeling and experiments has become a useful tool that is proving increasingly powerful for explaining biological complexity. As computational power is increasing, scientists are able to explore ever more complex models in finer detail and to explain very complex real world data. This work provides an overview of one-, two- and three-dimensional diffusion models for penetration into mammalian skin. Besides diffusive transport this includes also binding of substances to skin proteins and metabolism. These models are based on partial differential equations that describe the spatial evolution of the transport process through the biological barrier skin. Furthermore, the work focuses on analytical and numerical techniques for this type of equations such as discretization schemes or homogenization (upscaling) techniques. Finally, the work compares different geometry models with respect to the permeability.
Collapse
Affiliation(s)
- Arne Naegel
- Frankfurt University, Goethe Center for Scientific Computing, Kettenhofweg 139, 60325 Frankfurt am Main, Germany
| | | | | |
Collapse
|
6
|
Dukhin SS, Labib ME. Theory of effective drug release from medical implants based on the Higuchi model and physico-chemical hydrodynamics. Colloids Surf A Physicochem Eng Asp 2012; 409:10-20. [PMID: 24155569 DOI: 10.1016/j.colsurfa.2012.04.040] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
Abstract
Combining the approach of colloid transport with the generalized Higuchi theory of drug release and with the concept of minimum inhibitory concentration (MIC) known in microbiology, the theory of effective drug release from implants has been developed. Effective release of an antibiotic at a concentration above MIC is a necessary condition to achieve protection against infection from implants such as central catheters. The Higuchi theory in its present form is not predictive of the therapeutic effect from medical implants. The theory of effective release presented in this paper specifies two release modes, namely: one with therapeutic usefulness (effective release) and another without therapeutic effect. Therapeutic usefulness may be achieved when the antibiotic concentration, Cti , on the implant surface kills the organisms of interest and prevents the formation and propagation of biofilm when Cti exceeds the corresponding MIC of the released antibiotic compound. Currently, neither the Higuchi theory nor any other theory can provide such prediction. The present approach requires quantification of the antibiotic transport from the drug-polymer blend implant surface into the tissue and accounts for its coupling with drug diffusion inside the blend, a task that has not been developed in existing theories. Our solution to this task resulted in the derivation of an equation for the time of duration of effective release, Te , which depends on MIC, the Higuchi invariant and the characteristics of convective diffusion within the tissue. The latter characteristics include: diffusivity Dti and diffusion layer thickness δ which is controlled by the velocity of the interstitial fluid in tissue. A smaller Dti is favorable because transport from the catheter surface is weaker, while a thinner diffusion layer is harmful because this transport is stronger. The influence of the tangential component of interstitial velocity in the tissue is especially harmful because the diffusion within the incision exit site (IES) will be extremely enhanced such that it may decrease Cti to zero. The incorporation of convective diffusion into the theory of antibacterial protection by means of antibiotic release has revealed that physicochemical mechanisms predict the effectiveness of antibiotic-loaded catheters and defines the conditions necessary to achieve better protection by means of combining the level of catheter loading with antibiotics and the use of wound (IES) dressing.
Collapse
|
7
|
Lee PI. Modeling of drug release from matrix systems involving moving boundaries: Approximate analytical solutions. Int J Pharm 2011; 418:18-27. [DOI: 10.1016/j.ijpharm.2011.01.019] [Citation(s) in RCA: 46] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/07/2010] [Revised: 12/28/2010] [Accepted: 01/07/2011] [Indexed: 11/16/2022]
|
8
|
Frenning G. Modelling drug release from inert matrix systems: From moving-boundary to continuous-field descriptions. Int J Pharm 2011; 418:88-99. [DOI: 10.1016/j.ijpharm.2010.11.030] [Citation(s) in RCA: 48] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/06/2010] [Revised: 11/10/2010] [Accepted: 11/12/2010] [Indexed: 10/18/2022]
|
9
|
Labib ME, Brumlik CJ, Stoodley P, Dukhin SS, Davidson T, Tabani Y. The Long-term Release of Antibiotics From Monolithic Nonporous Polymer Implants for Use as Tympanostomy Tubes. Colloids Surf A Physicochem Eng Asp 2010; 254:331-337. [PMID: 21614132 DOI: 10.1016/j.colsurfa.2009.10.028] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Abstract
A technology is elaborated for the fabrication of a novel tympanostomy tube (TT) from solidified polymer melts (Elvax and Polyurethane) and antibiotics (Ciprofloxacin and Usnic acid) for insertion into tympanic membrane (ear drum) according to the established surgical procedure. The long-term in vitro release kinetics of the antibiotics into liquid water has been assessed using standard methods. The measured kinetic curves revealed two stages of antibiotic release into the finite space. During the first stage (fast), the fast release rate is almost invariant and is determined by the diffusion through the steady diffusion layer formed due to solution agitation. In this first stage, the influence of the initial internal transport is weak because it takes place at negligibly small distance from interface and accordingly, at negligibly concentration drop. After the antibiotic concentration decreases within the much broader layer of matrix near interface, the internal transport becomes important. This manifests itself as the second stage in measured kinetics of release curves which is characterized by a gradual decrease in rate. The minimum inhibition concentrations of three antibiotics/antimicrobial compounds for four bacterial species were measured. The first stage of fast release from the polymer implant lasts 6 days at a polymer loading by Ciprofloxacin (0.03 g/cm(3)) and this was sufficient for preventing biofilm formation on the surface of the implant material. The measured kinetic curves of drug release showed more rapid decrease in the release rate compared to the Higuchi approximation. Comparison with existing theories, which account for the finite rate of drug dissolution, showed that this may explain the observed deviation from the diffusion-controlled Higuchi model. Large dimensions of drug particles and their aggregation retard the dissolution stage and consequently the release rate. Melt blending was found to cause the drug particle aggregation within polymer matrixes which was confirmed by microscopic reexamination of the polymer implant materials.
Collapse
Affiliation(s)
- Mohamed E Labib
- Novaflux Technologies, 1 Wall Street, Princeton, NJ 08540, U.S.A
| | | | | | | | | | | |
Collapse
|
10
|
Papadokostaki K. Experimental realization of sustained simple kinetic regimes of release of particulate solutes subject to slow dissolution in the containing matrix. J Memb Sci 2009. [DOI: 10.1016/j.memsci.2008.10.021] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
11
|
Barocas V, Drasler W, Girton T, Guler I, Knapp D, Moeller J, Parsonage E. A dissolution-diffusion model for the TAXUS™ drug-eluting stent with surface burst estimated from continuum percolation. J Biomed Mater Res B Appl Biomater 2008; 90:267-74. [DOI: 10.1002/jbm.b.31282] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
|
12
|
Papadokostaki K, Stavropoulou A, Sanopoulou M, Petropoulos J. An advanced model for composite planar three-layer matrix-controlled release devices. J Memb Sci 2008. [DOI: 10.1016/j.memsci.2007.12.056] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
13
|
Cabrera MI, Luna JA, Grau RJ. Modeling of dissolution-diffusion controlled drug release from planar polymeric systems with finite dissolution rate and arbitrary drug loading. J Memb Sci 2006. [DOI: 10.1016/j.memsci.2006.02.025] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
14
|
Frenning G, Brohede U, Strømme M. Finite element analysis of the release of slowly dissolving drugs from cylindrical matrix systems. J Control Release 2005; 107:320-9. [PMID: 16081182 DOI: 10.1016/j.jconrel.2005.06.016] [Citation(s) in RCA: 44] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/21/2005] [Revised: 05/17/2005] [Accepted: 06/30/2005] [Indexed: 11/25/2022]
Abstract
Drug release from matrix systems of cylindrical shape is analyzed in detail by using the finite element method. The model used combines the Noyes-Whitney and diffusion equations, and thus takes the effects of a finite dissolution rate into account. The model is valid for all drug solubilities and dissolution rates, and allows accurate predictions of the drug release to be made. Anisotropic drug transport that may result from the manufacturing process is properly accounted for. Model calculations show that a finite dissolution rate may affect the release profile significantly, producing an initial delay. The equivalence between anisotropic release and isotropic release from a matrix with different dimensions is demonstrated. Comparisons are made with the predictions of a recently proposed pseudo-steady state (PSS) analysis of drug release from cylindrical matrices [Y. Zhou, J. S. Chu, T. Zhou, X. Y. Wu, Modeling of dispersed-drug release from two-dimensional matrix tablets, Biomaterials 26 (2005) 945-952]. This comparison reveals that important discrepancies exist between the numerical and analytical results, which are attributed to the simplifying assumption made in the PSS analysis that the region containing solid drug remains cylindrical in shape throughout the release process. The proposed model is shown to describe experimental release data well.
Collapse
Affiliation(s)
- Göran Frenning
- Department of Pharmacy, Uppsala University, Uppsala Biomedical Center, P. O. Box 580, SE-751 23 Uppsala, Sweden.
| | | | | |
Collapse
|
15
|
Cheung RY, Kuba R, Rauth AM, Wu XY. A new approach to the in vivo and in vitro investigation of drug release from locoregionally delivered microspheres. J Control Release 2004; 100:121-33. [PMID: 15491816 DOI: 10.1016/j.jconrel.2004.08.004] [Citation(s) in RCA: 18] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/11/2004] [Accepted: 08/16/2004] [Indexed: 10/26/2022]
Abstract
The purpose of this work was to determine the in vivo release profile of doxorubicin (Dox) delivered locoregionally by dextran-based microspheres (MS) and to develop an in vitro method for predicting in vivo drug release from MS-- in vitro-in vivo correlation (IVIVC). For the determination of in vivo Dox release, drug-loaded MS were placed into hollow fibers (HF) and implanted subcutaneously into C3H mice. Samples were retrieved at various times following implantation, MS removed from HF, and the amount of Dox remaining determined via ultraviolet/visible (UV/Vis) spectrophotometry. Various in vitro systems were designed and investigated for their ability to link in vivo and in vitro release profiles, including an open system (e.g. a column) with continuous flow of release medium at different flow rates and closed systems (e.g. a cuvette) using different release media and conditions. About 34% of loaded Dox was released from MS in vivo at 48 h. Only an incremental release was observed over the ensuing 72 h. The release kinetics of Dox from MS using three of the investigated in vitro systems, column system and HF immersed in a buffer solution or growth medium gave release profiles that were highly correlated with the in vivo release profile (r(2)>0.9). The relationships, both linear and non-linear, suggest that Level A IVIVC models can be developed for Dox release from locoregionally delivered MS using specially designed release systems.
Collapse
Affiliation(s)
- Richard Y Cheung
- Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada M5S 2S2
| | | | | | | |
Collapse
|
16
|
Frenning G. Theoretical investigation of drug release from planar matrix systems: effects of a finite dissolution rate. J Control Release 2003; 92:331-9. [PMID: 14568413 DOI: 10.1016/s0168-3659(03)00338-9] [Citation(s) in RCA: 50] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Drug release from planar matrix systems has been investigated with special emphasis on the influence of a finite dissolution rate on the drug release profile. A mathematical model of the drug dissolution and release processes was formulated in terms of two coupled nonlinear partial differential equations (PDEs). These were solved numerically by using well-established FORTRAN routines. An approximate analytical solution, valid during the early stages of the release process, was derived. The analytical solution was compared to the numerical one and to drug release models existing in the literature. From this comparison, it was established that the analytical approximation provided a good description of the major part of the release profile, irrespective of the dissolution rate. Existing literature models, based on instantaneous dissolution, were found to agree with the numerical solution only when drug dissolution proceeded very rapidly in comparison with the diffusion process. Consequently, the new analytical short-time approximation of the drug release complements the formulas existing in the literature, since it provides a superior description of the release of slowly dissolving drugs.
Collapse
Affiliation(s)
- Göran Frenning
- Department of Pharmacy, Uppsala University, P.O. Box 580, SE-751 23, Uppsala, Sweden.
| |
Collapse
|
17
|
Zhou Y, Wu XY. Modeling and analysis of dispersed-drug release into a finite medium from sphere ensembles with a boundary layer. J Control Release 2003; 90:23-36. [PMID: 12767704 DOI: 10.1016/s0168-3659(03)00128-7] [Citation(s) in RCA: 39] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
Mathematical models were developed and analytical solutions were derived for describing kinetics of dispersed-drug release into a finite external medium from multi-particulate systems, such as ensembles of matrix spheres and microcapsules with a diffusion boundary layer. The solutions can be used to compute profiles of the moving boundary of a dispersed drug and the amount of drug released for multiparticulate ensembles with various ratios of initial drug loading (C(0)) to drug solubility (C(s)) in a finite to infinite medium. They are also applicable to a single sphere without a boundary layer in a perfect sink. The determinants of release kinetics, such as the liquid volume, the initial drug loading, the boundary layer thickness, and the number of spheres in a population, were analyzed using the derived solutions. The effect of coating thickness and material on the release profiles of microcapsules was studied as well. Criteria were established for finding the conditions when drug release would stall due to saturation of the medium, which can be used to determine suitable liquid volume and time for refreshing the medium.
Collapse
Affiliation(s)
- Y Zhou
- AP-CAD Inc., M6S 4Z7, Toronto, Ontario, Canada
| | | |
Collapse
|
18
|
Tipre DN, Vavia PR. Formulation optimization and stability study of transdermal therapeutic system of nicorandil. Pharm Dev Technol 2003; 7:325-32. [PMID: 12229264 DOI: 10.1081/pdt-120005729] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
The aim of this research investigation was to fabricate acrylate-based stable transdermal therapeutic system (TTS) of nicorandil, which could deliver drug through transdermal route. Monolithic TTS was fabricated in pressure sensitive adhesives (PSAs)--(a) terpolymer (PSA1) of 2-ethylhexyl acrylate, methyl methacrylate, and acrylic acid, (b) copolymer (PSA2) of 2-ethylhexyl acrylate, methyl methacrylate, acrylic acid, and vinyl acetate, and (c) Eudragit E100 pressure sensitive adhesive (PSA3). To enhance the flux of nicorandil, skin permeation enhancer N-methyl-2-pyrrolidone (NMP) was investigated at different concentrations (0.05-5%) in PSAs. Fabricated TTS was evaluated for in-vitro release and skin permeation through guinea pig skin. Maximum flux of nicorandil was observed from Eudragit E100 based TTS and kept for stability study at refrigeration, 25 degrees C/30% RH and 30 degrees C/60% RH. Patches were evaluated for various physicochemical parameters. Formulation was observed to be relatively more stable at refrigeration. Shelf life of the formulation was found to be 270, 270, and 30 days at refrigeration, 25 degrees C/30% RH and 30 degrees C/60% RH conditions, respectively. Nicorandil could be successfully derived from Eudragit E100 based TTS, but attention needs to be given to improve its chemical stability in formulation.
Collapse
Affiliation(s)
- Dnyanesh N Tipre
- University Department of Chemical Technology, Pharmaceutical Division, University of Mumbai, Matunga, Mumbai 400 019, India
| | | |
Collapse
|
19
|
Abstract
The objective of the present research investigation was to fabricate an acrylate-based transdermal therapeutic system (TTS) of nitrendipine, which could deliver drug at maximum input rate so as to deliver drug in minimum patch size. Transdermal patches were fabricated using synthesized acrylate pressure-sensitive adhesives (PSAs): PSA1, PSA2, and commercially available PSA3 and PSA4 using d-limonene as permeation enhancer. Effect of concentration of d-limonene on permeation kinetics of nitrendipine in PSAs was studied. Fabricated TTS in mentioned PSAs were evaluated for in-vitro release and permeation kinetics through guinea-pig skin. Cumulative release of drug in PSA1, PSA2, PSA3, and PSA4 was observed to be 45%, 40%, 25%, and 25%, respectively, upto 24 hr. Flux of drug through guinea-pig skin calculated at 48 hr in PSA1, PSA2, PSA3, and PSA4, with and without d-limonene, was observed to be 0.346+/-0.10, 0.435+/-0.17, 0.410+/-0.17, and 0.162+/-0.06, and 0.625+/-0.19, 1.161+/-0.46, 0.506+/-0.17, and 0.520+/-0.18 (microg/cm2/hr), respectively. The TTS in PSA2 showed comparatively high flux and could deliver drug at high input rate through transdermal route. PSA2 was found to have good rate-controlling property and could be successfully employed in transdermal delivery of nitrendipine.
Collapse
Affiliation(s)
- Dnyanesh N Tipre
- University Department of Chemical Technology, Pharmaceutical Division, University of Mumbai, Matunga, Mumbai, India
| | | |
Collapse
|
20
|
Zhou Y, Wu XY. Theoretical analyses of dispersed-drug release from planar matrices with a boundary layer in a finite medium. J Control Release 2002; 84:1-13. [PMID: 12399163 DOI: 10.1016/s0168-3659(02)00263-8] [Citation(s) in RCA: 33] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
Analytical solutions for the kinetics of dispersed-drug release from planar matrices with a boundary layer in a well-stirred finite external medium were derived in a general and a simplified form. The general solutions are applicable for a broad range of the ratio of initial drug loading to drug solubility (e.g. C(0)/C(s)> or =3) till all dispersed drug is dissolved, while the simplified solutions describe the entire release process for higher C(0)/C(s) ratios (e.g. C(0)/C(s)> or =10). As the C(0)/C(s) ratio increased, the general solutions approached the exact solution from the lower bound, and the simplified solution from the upper bound. This property could be useful to find the lower and upper bound of an exact solution for the sink condition without a boundary layer when it is unknown. The current solutions can cover more scenarios than the existing analytical and approximate solutions. The formulas, with explicit expressions, can be readily applied to analyze determinants of release kinetics, including volume of external medium, initial drug loading, and boundary layer thickness. With the criterion established for finding the conditions of drug saturation in a medium, minimal liquid volume and maximal time for refreshing the medium can be determined.
Collapse
Affiliation(s)
- Y Zhou
- AP-CAD Inc., Ontario, M6S 4Z7, Toronto, Canada
| | | |
Collapse
|
21
|
Duc Hanh B, Neubert RH, Wartewig S. Investigation of drug release from suspension using FTIR-ATR technique: part II. Determination of dissolution coefficient of drugs. Int J Pharm 2000. [DOI: 10.1016/s0378-5173(00)00487-7] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
22
|
Katzhendler I, Mäder K, Friedman M. Correlation between drug release kinetics from proteineous matrix and matrix structure: EPR and NMR study. J Pharm Sci 2000; 89:365-81. [PMID: 10707017 DOI: 10.1002/(sici)1520-6017(200003)89:3<365::aid-jps8>3.0.co;2-d] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
The present study was conducted in order to probe the microstructure, microviscosity, and hydration properties of matrices containing two model drugs, naproxen sodium (NS) and naproxen (N), and egg albumin (EA) as matrix carrier. The results suggested that N release from EA matrix was controlled by a bulk erosion mechanism in combination with additional processes (crystal dissolution/crystallization rate) compared with NS matrix, which behaved as a non-erodible matrix and drug release occurred by diffusion through the gel. Using EPR technique it has been shown that incorporating NS into EA matrix strongly influences the microstructure of the protein gel, and hence the transport of the penetrant within the matrix, compared with matrices containing N. The presence of NS increased the protein chain mobility and hydration which supports our previous results showing that NS cause unfolding of EA. In contrast, N caused only marginal effect on EA chain mobility. The gel formed in EA/NS matrices was more porous compared with EA/N matrices as revealed by the lower rotational correlation time of PCA (lower microviscosity) in EA/NS matrices compared with EA/N. However, EA/N gelled matrices were more heterogeneous, i.e., containing a higher number of components having different mobility. The T(1) and T(2) relaxation studies by NMR provided an additional support for the higher chain hydration in EA/NS matrices compared with EA/N as indicated by the higher relaxation rates in the gelled matrices. Internal pH measurements by EPR revealed that the micro-pH inside 100% EA and 50/50 EA/N matrices were lower than 50/50 EA/NS matrices and in all cases lower than the penetrating buffer pH. The lower pH compartment formed in N matrices affected N solubility and crystal dissolution rate, which can explain its lower release rate compared with EA, from the same formulation. The EPR and NMR data supports our findings that NS caused unfolding of the protein, affected matrix structure, and converted it to a hydrophobic non-erodible matrix compared with EA/N matrix in which the native properties of EA were mainly retained.
Collapse
Affiliation(s)
- I Katzhendler
- Department of Pharmaceutics, School of Pharmacy, The Hebrew University of Jerusalem, P.O.B. 12065, Jerusalem 91120, Israel
| | | | | |
Collapse
|
23
|
Wu XY, Zhou Y. Studies of diffusional release of a dispersed solute from polymeric matrixes by finite element method. J Pharm Sci 1999; 88:1050-7. [PMID: 10514355 DOI: 10.1021/js9804361] [Citation(s) in RCA: 37] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
This paper presents systematic analyses by the finite element method of release kinetics of a dispersed solute from various matrixes (i.e. , slab, sphere, cylinder, and convex tablet), with or without boundary-layer resistance, into a finite or an infinite external volume. In the case of sink conditions, the numerical results agree well with the existing analytical solutions. For the problems of solute release into a finite external volume, where the analytical solutions are not available, this work has provided numerical solutions of the differential equations describing the release kinetics, moving boundaries, and concentration profiles. This work has also revealed the dependence of release kinetics on the initial solute loading, the external volume, and the boundary-layer thickness. The method presented here can describe the entire process of diffusional release before and after the dispersed solute has been dissolved without the pseudo steady-state assumption and it is applicable to both small and large ratio of initial solute loading to the solute solubility in the matrix.
Collapse
Affiliation(s)
- X Y Wu
- Department of Pharmaceutical Sciences, Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada M5S 2S2.
| | | |
Collapse
|
24
|
Kubota K, Twizell EH, Maibach HI. Drug release from a suspension with a finite dissolution rate: theory and its application to a betamethasone 17-valerate patch. J Pharm Sci 1994; 83:1593-9. [PMID: 7891281 DOI: 10.1002/jps.2600831115] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]
Abstract
A random walk method for a diffusion equation is applied to the model for a suspension with a finite dissolution rate developed by Ayres and Lindstrom in 1977. In the method, the diffusion of dissolved drug and dissolution of crystal are calculated separately using a simple BASIC program. The random walk method strictly meets the principle of the conservation of mass as the drug amount in each sublayer rather than the concentration at each subinterval is concerned in the ointment. The model is used to analyze the release of betamethasone 17-valerate from a pressure-sensitive silicone adhesive into a sink. The drug release from the 1.50 mg/mL patch shows no substantial discrepancy from that predicted by the classic suspension model assuming an infinite dissolution rate. However, the classic model overestimates the release from the 3.08 and 5.88 mg/mL patches. The disagreement is lessened when the dissolution rate is assumed to be finite. However, the model does not give a perfect explanation because the drug release from the 3.08 and 5.88 mg/mL patches in the early phase is faster than the model predicts.
Collapse
Affiliation(s)
- K Kubota
- Department of Dermatology, University of California--San Francisco, School of Medicine 94143-0989
| | | | | |
Collapse
|
25
|
Kubota K, Sznitowska M, Maibach HI. Percutaneous permeation of betamethasone 17-valerate from different vehicles. Int J Pharm 1993. [DOI: 10.1016/0378-5173(93)90217-4] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
26
|
Abstract
In vitro percutaneous permeation of betamethasone 17-valerate through excised human skin was studied. Pressure-sensitive silicone adhesive containing betamethasone 17-valerate in suspension was used as a vehicle. Steady-state flux through the split-thickness skin was similar to that through the isolated epidermis. However, the lag-time and half-life after removal of the vehicle were longer for the split-thickness skin than from epidermis. At steady state, 37% of the drug in the split-thickness skin was partitioned in dermis. When the kinetic parameters of a simple single-layer model are defined to specify the permeability coefficient and the drug amount in skin at steady state, this model can predict the longer half-life observed for the split-thickness skin sample compared with that for epidermis. The difference between the observed and theoretical values of the half-life after removal of the vehicle was within 23%. On the other hand, the lag-time had a large variation and the simple diffusion model failed to be predictive. A single-layer model described by two or three kinetic parameters may be able to describe percutaneous permeation kinetics even when the processes after the compound permeation through stratum corneum are not negligible. However, it is stressed that none of the kinetic parameters inherent in this simple model directly represents one of the single physicochemical parameters, such as diffusion and partition coefficients and path length of each skin layer.
Collapse
Affiliation(s)
- K Kubota
- Department of Dermatology, University of California, School of Medicine, San Francisco 94143-0989
| | | | | |
Collapse
|
27
|
Swarbrick J, Siverly JR. The influence of liquid crystalline phases on drug percutaneous absorption. II. Permeation studies through excised human skin. Pharm Res 1992; 9:1550-5. [PMID: 1488397 DOI: 10.1023/a:1015852022343] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
Abstract
The influence of liquid crystalline (LC) phases on the percutaneous absorption of a model compound (ploxicromil; PXC) was studied with the use of the phase diagram for the surfactant, oil, and water comprising the vehicles. Two separate sets of vehicles, representing two different tie lines lying in the L1 + LC phase region, were prepared in which the concentration of LC was varied over the range 0 to 100% along each tie line. In vitro permeation studies of PXC from these systems were conducted using excised human skin and the flux values determined as a function of the percentage LC present in the vehicles. In virtually all cases, the flux reached a peak at 5-10% LC and then decreased significantly as the fraction of LC present increased further. The pattern of behavior observed is discussed in terms of current theories describing membrane-controlled and vehicle-controlled diffusion, none of which adequately model the results obtained.
Collapse
Affiliation(s)
- J Swarbrick
- Division of Pharmaceutics, School of Pharmacy, University of North Carolina, Chapel Hill 27599-7360
| | | |
Collapse
|
28
|
|
29
|
Kubota K, Yamada T, Ogura A, Ishizaki T. A novel differentiation method of vehicle models for topically applied drugs: application to a therapeutic timolol patch. J Pharm Sci 1990; 79:179-84. [PMID: 2324968 DOI: 10.1002/jps.2600790220] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Abstract
A novel method to differentiate basic vehicle models for topically applied drugs is proposed. In this method, the rate of drug release as a function of time, obtained by using a flow-through cell, is plotted on both semilogarithmic and logarithmic scales. In the Solution Case, where all of the drug is dissolved in the vehicle, the profiles become linear on the semilogarithmic scale. However, in the Suspension Case, where the initial drug amount per vehicle volume is greater than the solubility of the drug and the vehicle contains finely dispersed drug, the profiles are linear on the logarithmic scale with a slope of -0.5. They abruptly depart from this pattern upon depletion of the suspended phase. The different attributes of the profiles for the drug release rate-time curves in these two cases can be visualized more clearly when vehicle thickness and drug concentration are varied. The theoretical principles are illustrated in profiles for the drug release-rate time plots of therapeutic patches containing the beta blocker timolol. This was formulated at different concentrations in an acryl copolymer with varied thickness. The release profiles were best fitted to the Solution Case treatment of the data.
Collapse
Affiliation(s)
- K Kubota
- Division of Clinical Pharmacology, National Medical Center, Tokyo, Japan
| | | | | | | |
Collapse
|
30
|
Addicks WJ, Flynn GL, Weiner N, Chiang CM. Drug transport from thin applications of topical dosage forms: development of methodology. Pharm Res 1988; 5:377-82. [PMID: 3266667 DOI: 10.1023/a:1015963728917] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/05/2023]
Abstract
There are presently no standards for in vitro research dealing with the release and delivery of drugs from semisolid dosage forms, largely because of inherent experimental difficulties. Among the problems, it has proven difficult to apply dosage forms to membranes mounted in in vitro diffusion cells in facsimile to the manner in which the dosage forms are applied clinically. In the present studies, methodology has been developed which allows films with thicknesses approaching clinical dimensions to be spread evenly over silicone rubber membranes. Using methyl p-aminobenzoate as a test permeant and gelled water and water/propylene glycol solvent systems as test vehicles, it has proven possible to spread films as thin as 75 microns, yielding highly reproducible delivery profiles. Using this application technique, it has been shown how the diffusive clearance of drug from films of fixed composition placed over a resistant membrane is dependent on the thickness of application. For a given medium and thickness of application, when the vehicle composition is enriched in propylene glycol, partitioning into the membrane is suppressed, resulting in a lessening of the absolute rate of delivery and, consequently, a prolongation of the period over which drug is released. Increasing the membrane's resistance, i.e., increasing the membrane's thickness, likewise slows down the absolute delivery rate, extending the effective period of total clearance of drug from the applied film.
Collapse
Affiliation(s)
- W J Addicks
- College of Pharmacy, University of Michigan, Ann Arbor 48109
| | | | | | | |
Collapse
|
31
|
Gienger G, Knoch A, Merkle HP. Modeling and numerical computation of drug transport in laminates: model case evaluation of transdermal delivery system. J Pharm Sci 1986; 75:9-15. [PMID: 3083091 DOI: 10.1002/jps.2600750104] [Citation(s) in RCA: 22] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
Abstract
This study reports on the modeling and numerical computation of drug transport from a laminated system into the skin. The model is based on the diffusion equation, on partitioning of the drug between individual layers of the device, and on continuity conditions for diffusive flux across the material interfaces of the system. Numerical computation of concentration profiles across the system was performed using a sophisticated software package designed for a general class of kinetics-diffusion problems, including time variable diffusion coefficients and interface conditions in case of nonhomogeneous media. This program is demonstrated by a model case evaluation of a transdermal delivery system for nitroglycerin and applies previous data on drug diffusion and partitioning in this system. The layers involved in drug transport are: a polymer film to carry the drug depot; a microporous membrane, the pores of which are filled with nonpolar liquids and solids; an adhesive layer; and a final layer representing the skin. Transport kinetics in the delivery system and the skin are being followed by plots of concentration profiles as a function of application time. Major concentration gradients indicate sites of release control. For practical purposes, the package is intended to serve for preformulation studies of laminated drug delivery systems.
Collapse
|
32
|
Abstract
A simplified mathematical model for dissolution-controlled transport from dispersed matrixes is presented. Analytical solutions have been obtained previously when solute diffusion totally controls the transport process. However, when solute dissolution offers the limiting resistance to mass transport, the solution reduces to a form where the mass released varies directly with time. Experimental release rates of a drug from a dispersed polymeric matrix into water were measured for a range of drug particle sizes in order to test the applicability of the proposed model; the agreement between theory and experimental is good.
Collapse
|
33
|
Seto YJ, Hsieh ST. Electromagnetic mediated pharmacokinetics in a three-layer diffusional system. Bull Math Biol 1982; 44:215-29. [PMID: 7074250 DOI: 10.1007/bf02463248] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/23/2023]
|
34
|
Turi JS, Danielson D, Woltersom JW. Effects of polyoxypropylene 15 stearyl ether and propylene glycol on percutaneous penetration rate of diflorasone diacetate. J Pharm Sci 1979; 68:275-80. [PMID: 423113 DOI: 10.1002/jps.2600680306] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Abstract
Theoretical models for percutaneous penetration are described, and a diffusion apparatus useful in the evaluation of transport kinetics of drugs applied to skin is discussed. Experimental data are presented for: (a) the flux of diflorasone diacetate through hairless mouse skin, (b) the percutaneous penetration profile of propylene glycol, (c) the effects of vehicle concentrations of polyoxypropylene 15 stearyl ether and propylene glycol on the percutaneous flux of diflorasone diacetate, (d) skin--vehicle partition coefficients of diflorasone diacetate, (e) the solubility profile of diflorasone diacetate as a function of solvent concentration, and (f) the alteration of the skin's resistance to the penetration of diflorasone diacetate due to propylene glycol. Excess solvent in a vehicle caused a decrease in the percutaneous flux of diflorasone diacetate. Formulations containing 0.05 and 0.1% diflorasone diacetate had similar penetration rates when the solvent concentration was optimized for each percentage of diflorasone diacetate.
Collapse
|
35
|
Lindstrom FT, Ayres JW. Diffusion model for drug release from suspensions II: release to a perfect sink. J Pharm Sci 1977; 66:662-8. [PMID: 874747 DOI: 10.1002/jps.2600660514] [Citation(s) in RCA: 22] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Abstract
Numerical mathematical methods are applied to a diffusion model based on physicochemical principles to predict drug release from suspensions of drug in semisolid vehicles. The predicted mass of drug released versus time curves using this model are in agreement with some reported experimental data but differ from predictions using the classical model for semisolid suspensions. The differences are discussed in relation to the drug dissolution rate and diffusion rate in the vehicle.
Collapse
|